Application of ursolic acid derivative in preparation of medicine for treating nervous system diseases

A neurological disease, ursolic acid technology, applied in the field of medicine, can solve the problems of difficult to obtain derivatives, few reaction sites, lack of active groups in the nucleus, etc., and achieve good nerve cell damage repair and anti-neuroinflammatory activity. Effect

Active Publication Date: 2021-07-13
NANTONG UNIVERSITY
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the special structure of pentacyclic triterpenoids, the parent nucleus lacks active groups and few reaction sites, it is difficult to obtain derivatives with hydroxyl, carbonyl and other modifications on the parent nucleus by conventional chemical reaction methods
Therefore, the chemical and pharmacological studies of ursolic acid derivatives with structural modification of the core are not yet comprehensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of ursolic acid derivative in preparation of medicine for treating nervous system diseases
  • Application of ursolic acid derivative in preparation of medicine for treating nervous system diseases
  • Application of ursolic acid derivative in preparation of medicine for treating nervous system diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Embodiment 1, structural formula is the preparation of the compound of formula I-formula IV

[0021] The invention adopts a microbial conversion method, uses ursolic acid as a raw material, and undergoes steps such as fermentation, extraction, and separation to prepare the compound of the invention. Circinella genus strains can be purchased from the Chinese Academy of Sciences Microbial Culture Collection Center (CGMCC), using potato medium, and stored on a solid slant medium in a refrigerator at 4°C.

[0022] Taking Circinella muscae CGMCC 3.2695 as an example, the process of preparing the compound whose structural formula is formula I-Formula IV is as follows:

[0023] 1) Fermentation, transformation and extraction

[0024] Put Circinella muscae CGMCC 3.2695 into two 250mL Erlenmeyer flasks (containing 100mL potato culture medium) as seed solution. After shaking and culturing on a shaker at 160 rpm and 26°C for 1 day, when the mycelium growth is in a vigorous stage,...

Embodiment 2

[0031] Example 2 Compounds Ⅰ-Ⅳ have repairing and protective activity on nerve cells damaged by hydrogen peroxide

[0032] (1) Experimental materials

[0033] CO 2 Incubator (Jouan IGO150); Microplate reader (Bio-TEK ELx800); Fluorescent inverted microscope (OlympusIX51); MTT cell proliferation and cytotoxicity detection kit (Biotech Institute), DMEM high glucose medium (Gibcol BRL ), fetal bovine serum, dimethyl sulfoxide (DMSO), trypsin (Shanghai Bioengineering Co., Ltd.), 30% hydrogen peroxide (H 2 o 2 ) (Tianjin Ruijinte Chemicals Co., Ltd.), SH-SY5Y cells (Tumor Institute, Chinese Academy of Medical Sciences).

[0034] (2) Experimental method

[0035] The MTT method was used to determine the H of each test compound 2 o 2 Influence of damaged SH-SY5Y cell viability: count the cells after digestion with trypsin, adjust the cell density of the cell suspension to 5×10 4 cells / mL, add 200 μL to each well of a 96-well culture plate, place in 5% CO 2 , 37°C constant temp...

Embodiment 3

[0042] Example 3 Anti-neuroinflammatory activity of compounds Ⅰ-Ⅳ of the present invention

[0043] 1) Experimental materials

[0044]Instruments and reagents: CO2 incubator (Jouan IGO150); microplate reader (Bio-TEK ELx800); fluorescent inverted microscope (Olympus IX51); MTT cell proliferation and cytotoxicity detection kit (Beiyuntian Biotechnology Institute), RPMI 1640 Medium (Gibcol BRL), microglial cells BV-2, RNase A, fetal bovine serum, dimethyl sulfoxide (DMSO), trypsin (Shanghai Bioengineering Co., Ltd.).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of medicines, and discloses application of ursolic acid derivatives in preparation of medicines for treating nervous system diseases. The ursolic acid is successfully subjected to structural modification by utilizing a microbial conversion technology, four novel compounds with parent nucleus structure modification are obtained, and in-vitro nerve cell injury protection tests and nerve microglia inflammation tests prove that the compounds have relatively good nerve cell protection activity and anti-neuroinflammation activity. The compound can be used as an active ingredient of medicines for treating neurodegenerative diseases, traumatic brain injury and apoplexy, and has wide application.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the application of ursolic acid derivatives in the preparation of medicines for treating nervous system diseases. Background technique [0002] With the intensification of aging, the incidence of neurodegenerative diseases, traumatic brain injury and stroke and other neurological diseases are increasing year by year. Current clinical drugs can only alleviate some symptoms, but cannot effectively prevent the occurrence of the disease, improve the cognitive status of patients and prevent the development of the disease. Finding active and effective treatment methods has become an urgent task in neuroscience and other related disciplines. During the occurrence and development of the above-mentioned diseases, the damage, loss or death of nerve cells in the brain is the most basic pathological change, which often causes severe damage to nerve function and leads to hemiplegia, aphas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/56A61P25/00A61P25/28A61P25/16A61P25/14A61P21/00A61P9/10C12P33/00C12R1/645
CPCA61K31/56A61P25/00A61P25/28A61P25/16A61P25/14A61P21/00A61P9/10C12P33/00
Inventor 陈广通陆游佳徐天怡储呈娇宋开南宋妍
Owner NANTONG UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap